
Journal of Alloys and Compounds p. 796 - 802 (2016)
Update date:2022-08-17
Topics:
Francis, P. Nisha
Dhanuskodi
Muneeswaran
Thomas, Anitta Rose
Giridharan
Bismuth ferrite (BFO) nanoparticles were synthesized via sol-gel route with malic acid as a chelating agent. Structural characterization by XRD reveals the formation of single phase rhombohedral BFO and FTIR (433, 546?cm?1) confirms the molecular structure. FESEM exhibits an agglomerated spherical morphology with an average particle size of 119?nm. The first and second order structural transitions have been detected at 821 (rhombohedral – orthorhombic) and 932?°C (orthorhombic – cubic) by DTA. Strong visible light absorption with a band gap of 1.92?eV and defect related emissions at blue (417,450?nm) and green (521?nm) regions have been observed. Multiferroic properties at room temperature show weak ferromagnetism with remnant magnetization (Mr) 0.179 emu/gm and ferroelectric behavior with remnant polarization (Pr) 0.08?μC/cm2. Dielectric measurements as a function of frequency (100?Hz–5?MHz) and temperature (30–450?°C) illustrate an evidence for magnetoelectric coupling with a peak at 350?°C indicating the magnetic phase transition. Third order nonlinear optical property studied by the open aperture Z-scan technique (Nd: YAG, 532?nm, 5?ns) shows the reverse saturable absorption (RSA) based optical limiting behavior.
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Shandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
Changzhou Litong Chemical Co., Ltd.
website:http://www.litonchem.com/
Contact:+86-519-86301238
Address:Laoba Rd, Hutang town Changzhou Jiangsu
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Doi:10.1016/j.jcat.2010.11.012
(2011)Doi:10.1039/c3cc48131j
(2014)Doi:10.1002/kin.20092
(2005)Doi:10.1016/j.molstruc.2018.04.031
(2018)Doi:10.1038/labinvest.3780182
(1921)Doi:10.1016/0040-4039(96)01577-8
(1996)